Mercia EIS review – Invizius

14th July, 2021

Invizius is developing solutions to improve the treatment and prognosis for dialysis patients, in particular through its flagship H-Guard solution.

Investment Associate, Rob Bennett, explains a little more about the importance of Mercia’s investment.

Back to videos

Loading...